2.4000
-0.8000
(-25.00%)
At close: January 30 at 5:24:48 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-30,272.0000
-22,608.0000
-26,240.0000
-23,573.0000
-23,206.0000
Investing Cash Flow
-2,178.0000
1,444.0000
4,006.0000
-38,224.0000
16,668.0000
Financing Cash Flow
33,507.0000
15,056.0000
20,438.0000
57,749.0000
17,866.0000
End Cash Position
8,784.0000
4,255.0000
10,587.0000
12,990.0000
16,831.0000
Interest Paid Supplemental Data
1,864.0000
1,111.0000
593.0000
682.0000
994.0000
Capital Expenditure
-77.0000
-297.0000
-316.0000
-97.0000
--
Issuance of Capital Stock
17,551.0000
14,089.0000
14,359.0000
50,407.0000
19,246.0000
Issuance of Debt
19,223.0000
--
9,126.0000
--
--
Repayment of Debt
-3,704.0000
-1,988.0000
-3,052.0000
-3,572.0000
-3,357.0000
Free Cash Flow
-30,349.0000
-22,905.0000
-26,556.0000
-23,670.0000
-23,206.0000
12/31/2020 - 4/4/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LCTX.TA Lineage Cell Therapeutics, Inc.
223.00
-5.55%
ORMP.TA Oramed Pharmaceuticals Inc.
796.60
-0.75%
CGEN.TA Compugen Ltd.
853.60
+2.14%
BONS.TA Bonus BioGroup Ltd.
17.40
+0.58%
NV4.F Cellectar Biosciences, Inc.
0.2160
+8.00%
0M4.DU Mersana Therapeutics Inc
0.5988
+1.39%
M55.F MacroGenics, Inc.
2.8800
-0.48%
1VT.DU Viking Therapeutics Inc
32.32
+0.53%
8AW0.BE Ocean Biomedical Inc
0.1930
+6.63%
3G0.BE Altimmune Inc
6.43
-4.20%